img

Global CEACAM1Antibody Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CEACAM1Antibody Market Insights, Forecast to 2034

CEACAM1 Antibody is a specific antibody for detecting and studying CEACAM1 protein (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1).
Global CEACAM1Antibody market is expected to reach to US$ 443.5 million in 2024, with a positive growth of %, compared with US$ 394.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CEACAM1Antibody industry is evaluated to reach US$ 894.4 million in 2029. The CAGR will be 12.4% during 2024 to 2029.
CEACAM1 is a cell adhesion molecule belonging to the CEA family that is widely distributed on the surface of many cell types, including epithelial cells, leukocytes, and immune cells. It plays an important role in biological processes such as cell adhesion, immune regulation, and tumor development. CEACAM1 antibody can be used to study the expression, distribution and relationship of CEACAM1 with cell signal transduction, adhesion, immune regulation, etc., which will help to understand the function of CEACAM1 in cell biology and disease mechanism. In addition, it may also have potential applications in cancer diagnosis and treatment research.
Report Covers
This report presents an overview of global CEACAM1Antibody market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global CEACAM1Antibody market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sino Biological, Inc.
Abcam
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
BioLegend
LifeSpan BioSciences, Inc
Elabscience Biotechnology Inc.
Boster Biological Technology
Merck
Wuhan Fine Biotech Co., Ltd.
ProSci Incorporated
Abbexa
Segment by Type
Monoclonal Antibody
Polyclonal Antibody

Segment by Application


Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ CEACAM1Antibody plant distribution, commercial date of CEACAM1Antibody, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, CEACAM1Antibody introduction, etc. CEACAM1Antibody Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of CEACAM1Antibody
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 CEACAM1Antibody Product Introduction
1.2 Market by Type
1.2.1 Global CEACAM1Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global CEACAM1Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global CEACAM1Antibody Sales Estimates and Forecasts 2018-2029
2.2 Global CEACAM1Antibody Revenue by Region
2.2.1 Global CEACAM1Antibody Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global CEACAM1Antibody Revenue by Region (2018-2024)
2.2.3 Global CEACAM1Antibody Revenue by Region (2024-2029)
2.2.4 Global CEACAM1Antibody Revenue Market Share by Region (2018-2029)
2.3 Global CEACAM1Antibody Sales Estimates and Forecasts 2018-2029
2.4 Global CEACAM1Antibody Sales by Region
2.4.1 Global CEACAM1Antibody Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global CEACAM1Antibody Sales by Region (2018-2024)
2.4.3 Global CEACAM1Antibody Sales by Region (2024-2029)
2.4.4 Global CEACAM1Antibody Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global CEACAM1Antibody Sales by Manufacturers
3.1.1 Global CEACAM1Antibody Sales by Manufacturers (2018-2024)
3.1.2 Global CEACAM1Antibody Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of CEACAM1Antibody in 2022
3.2 Global CEACAM1Antibody Revenue by Manufacturers
3.2.1 Global CEACAM1Antibody Revenue by Manufacturers (2018-2024)
3.2.2 Global CEACAM1Antibody Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by CEACAM1Antibody Revenue in 2022
3.3 Global Key Players of CEACAM1Antibody, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global CEACAM1Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global CEACAM1Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of CEACAM1Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of CEACAM1Antibody, Product Offered and Application
3.8 Global Key Manufacturers of CEACAM1Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global CEACAM1Antibody Sales by Type
4.1.1 Global CEACAM1Antibody Historical Sales by Type (2018-2024)
4.1.2 Global CEACAM1Antibody Forecasted Sales by Type (2024-2029)
4.1.3 Global CEACAM1Antibody Sales Market Share by Type (2018-2029)
4.2 Global CEACAM1Antibody Revenue by Type
4.2.1 Global CEACAM1Antibody Historical Revenue by Type (2018-2024)
4.2.2 Global CEACAM1Antibody Forecasted Revenue by Type (2024-2029)
4.2.3 Global CEACAM1Antibody Revenue Market Share by Type (2018-2029)
4.3 Global CEACAM1Antibody Price by Type
4.3.1 Global CEACAM1Antibody Price by Type (2018-2024)
4.3.2 Global CEACAM1Antibody Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global CEACAM1Antibody Sales by Application
5.1.1 Global CEACAM1Antibody Historical Sales by Application (2018-2024)
5.1.2 Global CEACAM1Antibody Forecasted Sales by Application (2024-2029)
5.1.3 Global CEACAM1Antibody Sales Market Share by Application (2018-2029)
5.2 Global CEACAM1Antibody Revenue by Application
5.2.1 Global CEACAM1Antibody Historical Revenue by Application (2018-2024)
5.2.2 Global CEACAM1Antibody Forecasted Revenue by Application (2024-2029)
5.2.3 Global CEACAM1Antibody Revenue Market Share by Application (2018-2029)
5.3 Global CEACAM1Antibody Price by Application
5.3.1 Global CEACAM1Antibody Price by Application (2018-2024)
5.3.2 Global CEACAM1Antibody Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada CEACAM1Antibody Market Size by Type
6.1.1 US & Canada CEACAM1Antibody Sales by Type (2018-2029)
6.1.2 US & Canada CEACAM1Antibody Revenue by Type (2018-2029)
6.2 US & Canada CEACAM1Antibody Market Size by Application
6.2.1 US & Canada CEACAM1Antibody Sales by Application (2018-2029)
6.2.2 US & Canada CEACAM1Antibody Revenue by Application (2018-2029)
6.3 US & Canada CEACAM1Antibody Market Size by Country
6.3.1 US & Canada CEACAM1Antibody Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada CEACAM1Antibody Sales by Country (2018-2029)
6.3.3 US & Canada CEACAM1Antibody Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe CEACAM1Antibody Market Size by Type
7.1.1 Europe CEACAM1Antibody Sales by Type (2018-2029)
7.1.2 Europe CEACAM1Antibody Revenue by Type (2018-2029)
7.2 Europe CEACAM1Antibody Market Size by Application
7.2.1 Europe CEACAM1Antibody Sales by Application (2018-2029)
7.2.2 Europe CEACAM1Antibody Revenue by Application (2018-2029)
7.3 Europe CEACAM1Antibody Market Size by Country
7.3.1 Europe CEACAM1Antibody Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe CEACAM1Antibody Sales by Country (2018-2029)
7.3.3 Europe CEACAM1Antibody Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China CEACAM1Antibody Market Size
8.1.1 China CEACAM1Antibody Sales (2018-2029)
8.1.2 China CEACAM1Antibody Revenue (2018-2029)
8.2 China CEACAM1Antibody Market Size by Application
8.2.1 China CEACAM1Antibody Sales by Application (2018-2029)
8.2.2 China CEACAM1Antibody Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia CEACAM1Antibody Market Size by Type
9.1.1 Asia CEACAM1Antibody Sales by Type (2018-2029)
9.1.2 Asia CEACAM1Antibody Revenue by Type (2018-2029)
9.2 Asia CEACAM1Antibody Market Size by Application
9.2.1 Asia CEACAM1Antibody Sales by Application (2018-2029)
9.2.2 Asia CEACAM1Antibody Revenue by Application (2018-2029)
9.3 Asia CEACAM1Antibody Sales by Region
9.3.1 Asia CEACAM1Antibody Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia CEACAM1Antibody Revenue by Region (2018-2029)
9.3.3 Asia CEACAM1Antibody Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America CEACAM1Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America CEACAM1Antibody Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America CEACAM1Antibody Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America CEACAM1Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America CEACAM1Antibody Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America CEACAM1Antibody Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America CEACAM1Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America CEACAM1Antibody Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America CEACAM1Antibody Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America CEACAM1Antibody Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sino Biological, Inc.
11.1.1 Sino Biological, Inc. Company Information
11.1.2 Sino Biological, Inc. Overview
11.1.3 Sino Biological, Inc. CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sino Biological, Inc. CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sino Biological, Inc. Recent Developments
11.2 Abcam
11.2.1 Abcam Company Information
11.2.2 Abcam Overview
11.2.3 Abcam CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Abcam CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abcam Recent Developments
11.3 Thermo Fisher Scientific (China) Co., Ltd.
11.3.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
11.3.2 Thermo Fisher Scientific (China) Co., Ltd. Overview
11.3.3 Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
11.4 Bio-Techne
11.4.1 Bio-Techne Company Information
11.4.2 Bio-Techne Overview
11.4.3 Bio-Techne CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Bio-Techne CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio-Techne Recent Developments
11.5 BioLegend
11.5.1 BioLegend Company Information
11.5.2 BioLegend Overview
11.5.3 BioLegend CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 BioLegend CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BioLegend Recent Developments
11.6 LifeSpan BioSciences, Inc
11.6.1 LifeSpan BioSciences, Inc Company Information
11.6.2 LifeSpan BioSciences, Inc Overview
11.6.3 LifeSpan BioSciences, Inc CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 LifeSpan BioSciences, Inc CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 LifeSpan BioSciences, Inc Recent Developments
11.7 Elabscience Biotechnology Inc.
11.7.1 Elabscience Biotechnology Inc. Company Information
11.7.2 Elabscience Biotechnology Inc. Overview
11.7.3 Elabscience Biotechnology Inc. CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Elabscience Biotechnology Inc. CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Elabscience Biotechnology Inc. Recent Developments
11.8 Boster Biological Technology
11.8.1 Boster Biological Technology Company Information
11.8.2 Boster Biological Technology Overview
11.8.3 Boster Biological Technology CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Boster Biological Technology CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Boster Biological Technology Recent Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Overview
11.9.3 Merck CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Merck CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Recent Developments
11.10 Wuhan Fine Biotech Co., Ltd.
11.10.1 Wuhan Fine Biotech Co., Ltd. Company Information
11.10.2 Wuhan Fine Biotech Co., Ltd. Overview
11.10.3 Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
11.11 ProSci Incorporated
11.11.1 ProSci Incorporated Company Information
11.11.2 ProSci Incorporated Overview
11.11.3 ProSci Incorporated CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 ProSci Incorporated CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ProSci Incorporated Recent Developments
11.12 Abbexa
11.12.1 Abbexa Company Information
11.12.2 Abbexa Overview
11.12.3 Abbexa CEACAM1Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Abbexa CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Abbexa Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 CEACAM1Antibody Industry Chain Analysis
12.2 CEACAM1Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 CEACAM1Antibody Production Mode & Process
12.4 CEACAM1Antibody Sales and Marketing
12.4.1 CEACAM1Antibody Sales Channels
12.4.2 CEACAM1Antibody Distributors
12.5 CEACAM1Antibody Customers
13 Market Dynamics
13.1 CEACAM1Antibody Industry Trends
13.2 CEACAM1Antibody Market Drivers
13.3 CEACAM1Antibody Market Challenges
13.4 CEACAM1Antibody Market Restraints
14 Key Findings in The Global CEACAM1Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global CEACAM1Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibody
Table 3. Major Manufacturers of Polyclonal Antibody
Table 4. Global CEACAM1Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global CEACAM1Antibody Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global CEACAM1Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global CEACAM1Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global CEACAM1Antibody Revenue Market Share by Region (2018-2024)
Table 9. Global CEACAM1Antibody Revenue Market Share by Region (2024-2029)
Table 10. Global CEACAM1Antibody Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global CEACAM1Antibody Sales by Region (2018-2024) & (K Units)
Table 12. Global CEACAM1Antibody Sales by Region (2024-2029) & (K Units)
Table 13. Global CEACAM1Antibody Sales Market Share by Region (2018-2024)
Table 14. Global CEACAM1Antibody Sales Market Share by Region (2024-2029)
Table 15. Global CEACAM1Antibody Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global CEACAM1Antibody Sales Share by Manufacturers (2018-2024)
Table 17. Global CEACAM1Antibody Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global CEACAM1Antibody Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of CEACAM1Antibody, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. CEACAM1Antibody Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global CEACAM1Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global CEACAM1Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CEACAM1Antibody as of 2022)
Table 23. Global Key Manufacturers of CEACAM1Antibody, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of CEACAM1Antibody, Product Offered and Application
Table 25. Global Key Manufacturers of CEACAM1Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global CEACAM1Antibody Sales by Type (2018-2024) & (K Units)
Table 28. Global CEACAM1Antibody Sales by Type (2024-2029) & (K Units)
Table 29. Global CEACAM1Antibody Sales Share by Type (2018-2024)
Table 30. Global CEACAM1Antibody Sales Share by Type (2024-2029)
Table 31. Global CEACAM1Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global CEACAM1Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global CEACAM1Antibody Revenue Share by Type (2018-2024)
Table 34. Global CEACAM1Antibody Revenue Share by Type (2024-2029)
Table 35. CEACAM1Antibody Price by Type (2018-2024) & (US$/Unit)
Table 36. Global CEACAM1Antibody Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global CEACAM1Antibody Sales by Application (2018-2024) & (K Units)
Table 38. Global CEACAM1Antibody Sales by Application (2024-2029) & (K Units)
Table 39. Global CEACAM1Antibody Sales Share by Application (2018-2024)
Table 40. Global CEACAM1Antibody Sales Share by Application (2024-2029)
Table 41. Global CEACAM1Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global CEACAM1Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global CEACAM1Antibody Revenue Share by Application (2018-2024)
Table 44. Global CEACAM1Antibody Revenue Share by Application (2024-2029)
Table 45. CEACAM1Antibody Price by Application (2018-2024) & (US$/Unit)
Table 46. Global CEACAM1Antibody Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada CEACAM1Antibody Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada CEACAM1Antibody Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada CEACAM1Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada CEACAM1Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada CEACAM1Antibody Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada CEACAM1Antibody Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada CEACAM1Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada CEACAM1Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada CEACAM1Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada CEACAM1Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada CEACAM1Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada CEACAM1Antibody Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada CEACAM1Antibody Sales by Country (2024-2029) & (K Units)
Table 60. Europe CEACAM1Antibody Sales by Type (2018-2024) & (K Units)
Table 61. Europe CEACAM1Antibody Sales by Type (2024-2029) & (K Units)
Table 62. Europe CEACAM1Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe CEACAM1Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe CEACAM1Antibody Sales by Application (2018-2024) & (K Units)
Table 65. Europe CEACAM1Antibody Sales by Application (2024-2029) & (K Units)
Table 66. Europe CEACAM1Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe CEACAM1Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe CEACAM1Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe CEACAM1Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe CEACAM1Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe CEACAM1Antibody Sales by Country (2018-2024) & (K Units)
Table 72. Europe CEACAM1Antibody Sales by Country (2024-2029) & (K Units)
Table 73. China CEACAM1Antibody Sales by Type (2018-2024) & (K Units)
Table 74. China CEACAM1Antibody Sales by Type (2024-2029) & (K Units)
Table 75. China CEACAM1Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 76. China CEACAM1Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 77. China CEACAM1Antibody Sales by Application (2018-2024) & (K Units)
Table 78. China CEACAM1Antibody Sales by Application (2024-2029) & (K Units)
Table 79. China CEACAM1Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 80. China CEACAM1Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia CEACAM1Antibody Sales by Type (2018-2024) & (K Units)
Table 82. Asia CEACAM1Antibody Sales by Type (2024-2029) & (K Units)
Table 83. Asia CEACAM1Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia CEACAM1Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia CEACAM1Antibody Sales by Application (2018-2024) & (K Units)
Table 86. Asia CEACAM1Antibody Sales by Application (2024-2029) & (K Units)
Table 87. Asia CEACAM1Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia CEACAM1Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia CEACAM1Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia CEACAM1Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia CEACAM1Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia CEACAM1Antibody Sales by Region (2018-2024) & (K Units)
Table 93. Asia CEACAM1Antibody Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America CEACAM1Antibody Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America CEACAM1Antibody Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America CEACAM1Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America CEACAM1Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America CEACAM1Antibody Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America CEACAM1Antibody Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America CEACAM1Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America CEACAM1Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America CEACAM1Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America CEACAM1Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America CEACAM1Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America CEACAM1Antibody Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America CEACAM1Antibody Sales by Country (2024-2029) & (K Units)
Table 107. Sino Biological, Inc. Company Information
Table 108. Sino Biological, Inc. Description and Major Businesses
Table 109. Sino Biological, Inc. CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sino Biological, Inc. CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sino Biological, Inc. Recent Developments
Table 112. Abcam Company Information
Table 113. Abcam Description and Major Businesses
Table 114. Abcam CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Abcam CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Abcam Recent Developments
Table 117. Thermo Fisher Scientific (China) Co., Ltd. Company Information
Table 118. Thermo Fisher Scientific (China) Co., Ltd. Description and Major Businesses
Table 119. Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Thermo Fisher Scientific (China) Co., Ltd. CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
Table 122. Bio-Techne Company Information
Table 123. Bio-Techne Description and Major Businesses
Table 124. Bio-Techne CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Bio-Techne CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Bio-Techne Recent Developments
Table 127. BioLegend Company Information
Table 128. BioLegend Description and Major Businesses
Table 129. BioLegend CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. BioLegend CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. BioLegend Recent Developments
Table 132. LifeSpan BioSciences, Inc Company Information
Table 133. LifeSpan BioSciences, Inc Description and Major Businesses
Table 134. LifeSpan BioSciences, Inc CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. LifeSpan BioSciences, Inc CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. LifeSpan BioSciences, Inc Recent Developments
Table 137. Elabscience Biotechnology Inc. Company Information
Table 138. Elabscience Biotechnology Inc. Description and Major Businesses
Table 139. Elabscience Biotechnology Inc. CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Elabscience Biotechnology Inc. CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Elabscience Biotechnology Inc. Recent Developments
Table 142. Boster Biological Technology Company Information
Table 143. Boster Biological Technology Description and Major Businesses
Table 144. Boster Biological Technology CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Boster Biological Technology CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Boster Biological Technology Recent Developments
Table 147. Merck Company Information
Table 148. Merck Description and Major Businesses
Table 149. Merck CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Merck CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Merck Recent Developments
Table 152. Wuhan Fine Biotech Co., Ltd. Company Information
Table 153. Wuhan Fine Biotech Co., Ltd. Description and Major Businesses
Table 154. Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Wuhan Fine Biotech Co., Ltd. CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Wuhan Fine Biotech Co., Ltd. Recent Developments
Table 157. ProSci Incorporated Company Information
Table 158. ProSci Incorporated Description and Major Businesses
Table 159. ProSci Incorporated CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. ProSci Incorporated CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. ProSci Incorporated Recent Developments
Table 162. Abbexa Company Information
Table 163. Abbexa Description and Major Businesses
Table 164. Abbexa CEACAM1Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Abbexa CEACAM1Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Abbexa Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. CEACAM1Antibody Distributors List
Table 170. CEACAM1Antibody Customers List
Table 171. CEACAM1Antibody Market Trends
Table 172. CEACAM1Antibody Market Drivers
Table 173. CEACAM1Antibody Market Challenges
Table 174. CEACAM1Antibody Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. CEACAM1Antibody Product Picture
Figure 2. Global CEACAM1Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global CEACAM1Antibody Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Polyclonal Antibody Product Picture
Figure 6. Global CEACAM1Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global CEACAM1Antibody Market Share by Application in 2022 & 2029
Figure 8. Flow Cytometry
Figure 9. ELISA
Figure 10. Western Blot
Figure 11. Immunoprecipitation
Figure 12. Immunofluorescence
Figure 13. Others
Figure 14. CEACAM1Antibody Report Years Considered
Figure 15. Global CEACAM1Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global CEACAM1Antibody Revenue 2018-2029 (US$ Million)
Figure 17. Global CEACAM1Antibody Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global CEACAM1Antibody Revenue Market Share by Region (2018-2029)
Figure 19. Global CEACAM1Antibody Sales 2018-2029 ((K Units)
Figure 20. Global CEACAM1Antibody Sales Market Share by Region (2018-2029)
Figure 21. US & Canada CEACAM1Antibody Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada CEACAM1Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe CEACAM1Antibody Sales YoY (2018-2029) & (K Units)
Figure 24. Europe CEACAM1Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China CEACAM1Antibody Sales YoY (2018-2029) & (K Units)
Figure 26. China CEACAM1Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) CEACAM1Antibody Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) CEACAM1Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America CEACAM1Antibody Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America CEACAM1Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The CEACAM1Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of CEACAM1Antibody in the World: Market Share by CEACAM1Antibody Revenue in 2022
Figure 33. Global CEACAM1Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global CEACAM1Antibody Sales Market Share by Type (2018-2029)
Figure 35. Global CEACAM1Antibody Revenue Market Share by Type (2018-2029)
Figure 36. Global CEACAM1Antibody Sales Market Share by Application (2018-2029)
Figure 37. Global CEACAM1Antibody Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada CEACAM1Antibody Sales Market Share by Type (2018-2029)
Figure 39. US & Canada CEACAM1Antibody Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada CEACAM1Antibody Sales Market Share by Application (2018-2029)
Figure 41. US & Canada CEACAM1Antibody Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada CEACAM1Antibody Revenue Share by Country (2018-2029)
Figure 43. US & Canada CEACAM1Antibody Sales Share by Country (2018-2029)
Figure 44. U.S. CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 45. Canada CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 46. Europe CEACAM1Antibody Sales Market Share by Type (2018-2029)
Figure 47. Europe CEACAM1Antibody Revenue Market Share by Type (2018-2029)
Figure 48. Europe CEACAM1Antibody Sales Market Share by Application (2018-2029)
Figure 49. Europe CEACAM1Antibody Revenue Market Share by Application (2018-2029)
Figure 50. Europe CEACAM1Antibody Revenue Share by Country (2018-2029)
Figure 51. Europe CEACAM1Antibody Sales Share by Country (2018-2029)
Figure 52. Germany CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 53. France CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 55. Italy CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 56. Russia CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 57. China CEACAM1Antibody Sales Market Share by Type (2018-2029)
Figure 58. China CEACAM1Antibody Revenue Market Share by Type (2018-2029)
Figure 59. China CEACAM1Antibody Sales Market Share by Application (2018-2029)
Figure 60. China CEACAM1Antibody Revenue Market Share by Application (2018-2029)
Figure 61. Asia CEACAM1Antibody Sales Market Share by Type (2018-2029)
Figure 62. Asia CEACAM1Antibody Revenue Market Share by Type (2018-2029)
Figure 63. Asia CEACAM1Antibody Sales Market Share by Application (2018-2029)
Figure 64. Asia CEACAM1Antibody Revenue Market Share by Application (2018-2029)
Figure 65. Asia CEACAM1Antibody Revenue Share by Region (2018-2029)
Figure 66. Asia CEACAM1Antibody Sales Share by Region (2018-2029)
Figure 67. Japan CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 71. India CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America CEACAM1Antibody Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America CEACAM1Antibody Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America CEACAM1Antibody Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America CEACAM1Antibody Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America CEACAM1Antibody Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America CEACAM1Antibody Sales Share by Country (2018-2029)
Figure 78. Brazil CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 81. Israel CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries CEACAM1Antibody Revenue (2018-2029) & (US$ Million)
Figure 83. CEACAM1Antibody Value Chain
Figure 84. CEACAM1Antibody Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries